Next-generation DES: the COMBO dual therapy stent with Genous endothelial progenitor capturing technology and an abluminal sirolimus matrix

References

• Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003;108(7):788-94
   PubMed Web of Science ®Google Scholar
• Fajadet J, Wijns W, Laarman GJ, et al. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial. Minerva Cardioangiol 2007;55(1):1-18
   PubMedGoogle Scholar
• Grube E, Silber S, Hauptmann KE, et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107(1):38-42
   PubMed Web of Science ®Google Scholar
• Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346(23):1773-80
   PubMed Web of Science ®Google Scholar
• Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349(14):1315-23
   PubMed Web of Science ®Google Scholar
• Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007;27(7):1500-10
   PubMed Web of Science ®Google Scholar
• Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115(18):2435-41
   PubMed Web of Science ®Google Scholar
• Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293(17):2126-30
   PubMed Web of Science ®Google Scholar
• Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48(1):193-202
   PubMed Web of Science ®Google Scholar
• Ong AT, McFadden EP, Regar E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45(12):2088-92
   PubMed Web of Science ®Google Scholar
• Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005;46(2):231-6
   PubMed Web of Science ®Google Scholar
• Raber L, Magro M, Stefanini GG, et al. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study. Circulation 2012;125(9):1110-21
   PubMed Web of Science ®Google Scholar
• Larsen K, Cheng C, Tempel D, et al. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model. Eur Heart J 2012;33(1):120-8
   PubMed Web of Science ®Google Scholar
• Aoki J, Serruys PW, van BH, et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 2005;45(10):1574-9
   PubMed Web of Science ®Google Scholar
• Duckers HJ, Silber S, de WR, et al. Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. EuroIntervention 2007;3(1):67-75
   PubMedGoogle Scholar
• Duckers HJ, Soullie T, den Heijer P, et al. Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent). EuroIntervention 2007;3(3):350-8
   PubMedGoogle Scholar
• Beijk MA, Klomp M, van GN, et al. Two-year follow-up of the Genous endothelial progenitor cell capturing stent versus the Taxus Liberte stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Catheter Cardiovasc Interv 2011;78(2):189-95
   PubMed Web of Science ®Google Scholar
• Haude M, Lee SW, Worthley SG, et al. The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent. JACC Cardiovasc Interv 2013;6(4):334-43
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275(5302):964-7
   PubMed Web of Science ®Google Scholar
• Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85(3):221-8
   PubMed Web of Science ®Google Scholar
• Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105(1):71-7
   PubMed Web of Science ®Google Scholar
• Kong D, Melo LG, Mangi AA, et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004;109(14):1769-75
   PubMed Web of Science ®Google Scholar
• Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95(3):952-8
   PubMed Web of Science ®Google Scholar
• Sieveking DP, Buckle A, Celermajer DS, Ng MK. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008;51(6):660-8
   PubMed Web of Science ®Google Scholar
• Chen JZ, Zhang FR, Tao QM, et al. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 2004;107(3):273-80
   PubMed Web of Science ®Google Scholar
• Heiss C, Keymel S, Niesler U, et al. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005;45(9):1441-8
   PubMed Web of Science ®Google Scholar
• Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348(7):593-600
   PubMed Web of Science ®Google Scholar
• Hoetzer GL, MacEneaney OJ, Irmiger HM, et al. Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. Am J Cardiol 2007;99(1):46-8
   PubMed Web of Science ®Google Scholar
• Ii M, Takenaka H, Asai J, et al. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ Res 2006;98(5):697-704
   PubMed Web of Science ®Google Scholar
• Michaud SE, Dussault S, Haddad P, et al. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006;187(2):423-32
   PubMed Web of Science ®Google Scholar
• Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003;108(4):457-63
   PubMed Web of Science ®Google Scholar
• Scheubel RJ, Zorn H, Silber RE, et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003;42(12):2073-80
   PubMed Web of Science ®Google Scholar
• Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002;106(22):2781-6
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89(1):E1-7
   PubMed Web of Science ®Google Scholar
• Heeschen C, Lehmann R, Honold J, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004;109(13):1615-22
   PubMed Web of Science ®Google Scholar
• Massa M, Rosti V, Ferrario M, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005;105(1):199-206
   PubMed Web of Science ®Google Scholar
• Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103(23):2776-9
   PubMed Web of Science ®Google Scholar
• Wojakowski W, Kucia M, Kazmierski M, et al. Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart 2008;94(1):27-33
   PubMed Web of Science ®Google Scholar
• George J, Goldstein E, Abashidze S, et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 2004;25(12):1003-8
   PubMed Web of Science ®Google Scholar
• Banerjee S, Brilakis E, Zhang S, et al. Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis 2006;189(1):70-5
   PubMed Web of Science ®Google Scholar
• Bonello L, Basire A, Sabatier F, et al. Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease. J Thromb Haemost 2006;4(5):979-81
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Aicher A, Vasa M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001;108(3):391-7
   PubMed Web of Science ®Google Scholar
• Heeschen C, Aicher A, Lehmann R, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003;102(4):1340-6
   PubMed Web of Science ®Google Scholar
• Landmesser U, Engberding N, Bahlmann FH, et al. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 2004;110(14):1933-9
   PubMed Web of Science ®Google Scholar
• Laufs U, Werner N, Link A, et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004;109(2):220-6
   PubMed Web of Science ®Google Scholar
• Strehlow K, Werner N, Berweiler J, et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003;107(24):3059-65
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001;103(24):2885-90
   PubMed Web of Science ®Google Scholar
• Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002;105(25):3017-24
   PubMed Web of Science ®Google Scholar
• Rogers C, Parikh S, Seifert P, Edelman ER. Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair. Circulation 1996;94(11):2909-14
   PubMed Web of Science ®Google Scholar
• Kipshidze N, Dangas G, Tsapenko M, et al. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 2004;44(4):733-9
   PubMed Web of Science ®Google Scholar
• Ong AT, Aoki J, Kutryk MJ, Serruys PW. How to accelerate the endothelialization of stents. Arch Mal Coeur Vaiss 2005;98(2):123-6
   PubMedGoogle Scholar
• Bjorkerud S, Bondjers G. Arterial repair and atherosclerosis after mechanical injury. 5. Tissue response after induction of a large superficial transverse injury. Atherosclerosis 1973;18(2):235-55
   PubMed Web of Science ®Google Scholar
• Haudenschild CC, Schwartz SM. Endothelial regeneration. II. Restitution of endothelial continuity. Lab Invest 1979;41(5):407-18
   PubMed Web of Science ®Google Scholar
• van Beusekom HM, Ertas G, Sorop O, et al. The Genous endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries. Catheter Cardiovasc Interv 2012;79(2):231-42
   PubMed Web of Science ®Google Scholar
• Lehtinen T, Kiviniemi TO, Ylitalo A, et al. Early vascular healing after endothelial progenitor cell capturing stent implantation. J Invasive Cardiol 2012;24(12):631-5
   PubMed Web of Science ®Google Scholar
• den Dekker WK, Houtgraaf JH, Onuma Y, et al. Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (GenousStent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. Atherosclerosis 2011;219(1):245-52
   PubMed Web of Science ®Google Scholar
• Silber S, Damman P, Klomp M, et al. Clinical results after coronary stenting with the Genous Bio-engineered R stent: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry. EuroIntervention 2011;6(7):819-25
   PubMed Web of Science ®Google Scholar
• Damman P, Klomp M, Beijk MA, et al. Twelve-month outcomes after coronary stenting with the Genous bio-engineered R Stent in diabetic patients from the e-HEALING registry. J Interv Cardiol 2011;24(4):285-94
   PubMed Web of Science ®Google Scholar
• Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004;109(16):1930-2
   PubMed Web of Science ®Google Scholar
• Park DW, Park SW, Park KH, et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 2006;98(3):352-6
   PubMed Web of Science ®Google Scholar
• Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006;113(24):2803-9
   PubMed Web of Science ®Google Scholar
• Damman P, Klomp M, Silber S, et al. Duration of dual antiplatelet therapy and outcomes after coronary stenting with the Genous bio-engineered R stent in patients from the e-HEALING registry. Catheter Cardiovasc Interv 2012;79(2):243-52
   PubMed Web of Science ®Google Scholar
• Sangiorgi GM, Morice MC, Bramucci E, et al. Evaluating the safety of very short-term (10 days) dual antiplatelet therapy after Genous bio-engineered R stent implantation: the multicentre pilot GENOUS trial. EuroIntervention 2011;7(7):813-19
   PubMed Web of Science ®Google Scholar
• Martin-Yuste V, Brugaletta S, Ferreira-Gonzalez I, et al. Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry. EuroIntervention 2011;6(7):831-7
   PubMed Web of Science ®Google Scholar
• Lee YP, Tay E, Lee CH, et al. Endothelial progenitor cell capture stent implantation in patients with ST-segment elevation acute myocardial infarction: one year follow-up. EuroIntervention 2010;5(6):698-702
   PubMed Web of Science ®Google Scholar
• Low AF, Lee CH, Teo SG, et al. Effectiveness and safety of the genous endothelial progenitor cell-capture stent in acute ST-elevation myocardial infarction. Am J Cardiol 2011;108(2):202-5
   PubMed Web of Science ®Google Scholar
• Bystron M, Cervinka P, Spacek R, et al. Randomized comparison of endothelial progenitor cells capture stent versus cobalt-chromium stent for treatment of ST-elevation myocardial infarction. Six-month clinical, angiographic, and IVUS follow-up. Catheter Cardiovasc Interv 2010;76(5):627-31
   PubMed Web of Science ®Google Scholar
• Kastrati A, Mehilli J, Dirschinger J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 2001;103(23):2816-21
   PubMed Web of Science ®Google Scholar
• Wojakowski W, Pyrlik A, Krol M, et al. Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial). Minerva Cardioangiol 2013;61(3):301-11
   PubMed Web of Science ®Google Scholar
• Klomp M, Beijk MA, Varma C, et al. 1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents. JACC Cardiovasc Interv 2011;4(8):896-904
   PubMed Web of Science ®Google Scholar
• Wohrle J, Birkemeyer R, Markovic S, et al. Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease. Heart 2011;97(16):1338-42
   PubMed Web of Science ®Google Scholar
• Gallo R, Padurean A, Jayaraman T, et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 1999;99(16):2164-70
   PubMed Web of Science ®Google Scholar
• Roque M, Cordon-Cardo C, Fuster V, et al. Modulation of apoptosis, proliferation, and p27 expression in a porcine coronary angioplasty model. Atherosclerosis 2000;153(2):315-22
   PubMed Web of Science ®Google Scholar
• Nakazawa G, Granada JF, Alviar CL, et al. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc Interv 2010;3(1):68-75
   PubMed Web of Science ®Google Scholar
• Granada JF, Inami S, Aboodi MS, et al. Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circ Cardiovasc Interv 2010;3(3):257-66
   PubMed Web of Science ®Google Scholar
• Landmesser U, Wijns W, Barbato E, et al. TCT-282 The REMEDEE OCT study: a prospective randomized study of the early vascular healing of a novel dual therapy stent in comparison with an everolimus eluting stent. 2012. Poster presentation at the transcatheter cardiovascular therapeutics; Miami, FL, USA; 2012
   Google Scholar